Neuren Pharmaceuticals | NEU - Market Capitalization


Neuren Pharmaceuticals reported AUD2.83B in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 7M 2M Mar/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Clinuvel Pharmaceuticals AUD 625.5M 105.22M Dec/2025
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Genetic Signatures AUD 10.44M 46.34M Aug/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Medical Developments International AUD 37.11M 25.41M Aug/2026
Neuren Pharmaceuticals AUD 2.44B 80.57M Aug/2026
Organon & Co USD 1.57B 290M Mar/2026
Paradigm Biopharmaceuticals AUD 61.46M 84.24M Aug/2026
PYC Therapeutics AUD 9.4B 8.44B Aug/2026
Starpharma Holdings AUD 306.97M 156.41M Aug/2026
Tectonic Therapeutic USD 580M 190M Mar/2026
Telix Pharmaceuticals AUD 5.07B 5.81B Dec/2025
Viatris USD 20.96B 2.47B Aug/2026
Xeris Pharmaceuticals USD 1000M 303M Mar/2026